Detalhe da pesquisa
1.
Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.
Respir Res
; 24(1): 290, 2023 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37978492
2.
A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
Eur Respir J
; 57(6)2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33334936
3.
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma.
J Pharmacol Exp Ther
; 367(3): 405-413, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30217958
4.
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 196(4): 438-446, 2017 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28375647
5.
Reply to Suissa and Ariel: The FULFIL Trial.
Am J Respir Crit Care Med
; 197(4): 542-543, 2018 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28950068
6.
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 197(9): 1230-1231, 2018 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29241016
7.
A new class of bronchodilator improves lung function in COPD: a trial with GSK961081.
Eur Respir J
; 42(4): 972-81, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23429913
8.
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".
Am J Respir Crit Care Med
; 196(8): 1083-1084, 2017 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28534669
9.
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma.
Chest
; 162(2): 297-308, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35248549
10.
Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial.
Int J Chron Obstruct Pulmon Dis
; 17: 2043-2052, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36072608
11.
TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow.
Int J Chron Obstruct Pulmon Dis
; 16: 2455-2465, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34511891
12.
FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD.
BMJ Open
; 11(3): e042526, 2021 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33753437
13.
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.
Biomark Insights
; 12: 1177271917730306, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28959121
14.
Effect of beclomethasone dipropionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymphocytes in chronic sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis
; 22(3): 214-21, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16315785
15.
Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and ß2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.
Drugs R D
; 15(3): 281-91, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26286203